trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'destiny,crc,02']
now live at #asco23 presenting destiny-crc02 of tdx in heavily pretreated met her2 #crcsm orr: 37.8%
dor: 8.1 months pfs: 5.8 months at 5.4 mg/kg #precisionmedicine 
Oncologist focused on #PrecisionOncology 🎯 & #PancreaticCancer 💜 •@myesmo faculty• #MissionCancer Board🇪🇺•Rolling with @OncoAlert 🚨 •Views are my own•